Try our Advanced Search for more refined results

Merck Swaps Lead Attorney For Vioxx Appeal

By Erin Coe (August 11, 2009, 10:49 PM EDT) -- Months after the U.S. Supreme Court agreed to hear Merck & Co. Inc.'s appeal of a decision that reinstated a securities class action alleging it concealed the health risks of its recalled painkiller Vioxx, the pharmaceutical giant has reportedly switched up its lead counsel, making its longtime attorney from Cravath Swaine & Moore LLP take a backseat....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!